Introduction: The evaluation and prescription of psychotropic drugs in oncologic setting is of particular\r\nimportance because of cancer patient�´s susceptibility to drug interactions.\r\nObjectives: Describe the frequency and type of comorbidities and the standard prescription of pharmaceuticals\r\nin a sample of cancer patients. Secondarily, reflect on the importance of clinical pharmacological interactions in\r\nthis context, particularly in the prescription of psychotropic drugs. Material/methods: Descriptive study of a sample\r\nof patients referred for the first time to the Psycho-Oncology Unit of IPOCFG, between October and December\r\n2011. A retrospective collection of the socio-demographic and clinical variables was made by consulting the clinical\r\nprocesses.\r\nResults: From the sample of 60 patients included for analysis, 48,3% of the patients were on antineoplasic\r\nmedication, 46,7% had prior psychiatric history and 70% were on psychotropic drugs; 75% presented other\r\ncomorbidities. Only 8,3% of patients were free of medication and, from those under it, 63,6% consumed three or\r\nmore distinct pharmacological classes.\r\nConclusions: There is a high frequency of co-morbidities and co-prescription of several classes of drugs which\r\npose cancer patients at risk of interactions. It is important that physicians are able to predict these phenomena to\r\nprevent the loss of efficiency and minimize the adverse effects, particularly of antineoplastic.
Loading....